Finance

Lists
Outlook: 85.7% bullish·0.0% bearish
Go to analysis
GRDN:NYSE
Guardian Pharmacy Services Inc
$49.49
-0.72%
(-0.36) 1D
Nov 11, 10:09:34 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GRDN...
Open
$49.75
High
$50.10
Low
$49.28
Mkt. cap
3.14B
Avg. vol.
486.48K
Volume
36.44K
P/E ratio
42.81
52-wk high
$50.17
52-wk low
$26.34
EPS
$1.16
Shares outstanding
63.32M
No. of employees
4K
Open
$49.75
High
$50.10
Low
$49.28
Mkt. cap
3.14B
Avg. vol.
486.48K
Volume
36.44K
P/E ratio
42.81
52-wk high
$50.17
52-wk low
$26.34
EPS
$1.16
Shares outstanding
63.32M
No. of employees
4K
News stories
From web sources and news partners
About Guardian Pharmacy Services Inc
CEO-
Employees3.6K
Founded2003
HeadquartersAtlanta, Georgia, United States
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 5 analysts giving stock ratings to GRDN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for GRDN in the last 3 months.
Highest
Current $49.49
$51.00 (+3.05%)
Average
$49.25 (-0.48%)
Lowest
$47.00 (-5.03%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allen Lutz
Bank of America Securities
Buy
Maintained
$47.00
-5%
11/10/2026
David S Macdonald
Truist Financial
Buy
Reiterated
$51.00
+3.1%
11/06/2026
Michael Wiederhorn
Oppenheimer
Buy
Maintained
$49.00
-1%
11/06/2026
Unknown Analyst
Stephens
Buy
Reiterated
$50.00
+1%
11/06/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
-
-
11/06/2026
Zach Haggerty‏
KeyBanc
Buy
Maintained
$52.00
+5.1%
10/21/2026
Unknown Analyst
KeyBanc
Buy
Initiated
$52.00
+5.1%
09/22/2026
Richard Newitter
Truist Financial
Buy
Maintained
$47.00
-5%
06/22/2026
Brian Tanquilut
Jefferies
Buy
Reiterated
$50.00
+1%
06/15/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
$0.33 / $0.31
+5.00%beat
Revenue / Est. (USD)
371.07M / 365.76M
+1.45%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
397.62M
336.60M
351.77M
371.07M
Cost of goods sold
312.11M
260.29M
271.72M
285.85M
Cost of revenue
312.11M
260.29M
271.72M
285.85M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
50.14M
55.43M
67.80M
60.14M
Operating expense
50.14M
55.43M
67.80M
60.14M
Total operating expenses
362.25M
315.72M
339.53M
345.98M
Operating income
35.37M
20.88M
12.24M
25.08M
Other non operating income
500.00K
772.00K
9.30M
1.09M
EBT including unusual items
31.10M
18.29M
29.79M
25.98M
EBT excluding unusual items
35.70M
21.50M
21.39M
26.00M
Income tax expense
9.83M
4.75M
7.67M
6.86M
Effective tax rate
31.62%
25.96%
25.75%
26.40%
Other operating expenses
-
-
-
-
Net income
20.92M
13.30M
21.87M
18.68M
Net profit margin
5.26%
3.95%
6.22%
5.03%
Earnings per share
0.37
0.29
0.29
0.33
Interest and investment income
-
-
-
-
Interest expense
-163.00K
-154.00K
-154.00K
-177.00K
Net interest expenses
-163.00K
-154.00K
-154.00K
-177.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
41.11M
26.85M
18.05M
31.02M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps